EYE 1.39% 18.3¢ nova eye medical limited

Following a comprehensive evaluation that includes both...

  1. 4,809 Posts.
    lightbulb Created with Sketch. 508
    Following a comprehensive evaluation that includes both fundamental and technical analysis, as well as an in-depth assessment of prevailing investor sentiment and consultations with industry experts, it has become apparent that EYE is currently trading at a premium relative to its intrinsic value. Based on this analysis, I project that EYE will undergo a gradual correction towards its fair value, which I estimate to lie between $0.175 and $0.19. However, this price adjustment is unlikely to occur in a straightforward manner; rather, I anticipate a series of intermittent rallies and pullbacks as the stock price trends downwards towards these more sustainable levels.

    Stonks92
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.